Navigation Links
Avion Pharmaceuticals, LLC., announces further expansion of their Women's Health Sales Team
Date:4/16/2013

ATLANTA, April 16, 2013 /PRNewswire/ -- Avion Pharmaceuticals, a specialty pharmaceutical company, announces the addition of 45 sales representatives to support their Women's Health Care and Dermatology portfolio of products.  The new sales team has joined the existing 40 representatives in promoting the Prenate® prenatal vitamin family of products along with Nicomide® for inflammatory acne.  In addition, the expanded Avion sales team of 85 representatives will be focused on the launch of FeRiva™ a new prescription iron supplement.  FeRiva delivers two forms of iron utilizing a patented INNER CAP multi-compartment capsule technology.  FeRiva contains 75 mg of elemental iron that includes Ferrochel® (Ferrous Bis-glycinate Sulfate and Ferronyl® (Carbonyl Iron), two preferred forms of iron for improved tolerability and compliance.

"The expansion of our sales team provides the critical level of sales support needed to effectively promote our portfolio of products to our prescriber community.  Avion is well-positioned for continued growth by providing a suite of products that will meet patient needs and our team of sales professionals is poised for success," stated Mike Sullivan , Vice President, Sales and Marketing for Avion Pharmaceuticals. 

"Avion Pharmaceuticals is excited to continue our focused efforts on nurturing the health and nutritional needs of women.  Our sales force expansion is being executed at the optimal juncture in our corporate history to support the progress we have planned for continued growth," added Mark Pugh , CEO for Avion Pharmaceuticals.

About Avion Pharmaceuticals, LLC.
Avion Pharmaceuticals, LLC. is a Specialty Pharmaceutical company formed to develop and market a portfolio of innovative pharmaceutical products in the Women's Heath and Dermatology therapeutic areas.  Avion Pharmaceuticals focuses on identifying opportunities to acquire and enhance the market potential of innovative, commercially available therapeutics and late-stage development drugs to fulfill unmet medical needs.  For additional information about Avion Pharmaceuticals please contact the company at 678-325-5188.

Ferronyl is a registered trademark of ISP Investments, Inc. PureWay-C is a registered trademark of Innovation Laboratories, Inc. Ferrochel is a registered trademark of Albion Laboratories, Inc. covered by U.S. Patents 6,716,814 & 7,838,042.
Covered by one or more claims of U.S. Patent # 7,670,612 (INNERCAP Technologies, Inc).

FeRiva™ is a trademark of Avion Pharmaceuticals, LLC. Under license from Acella Pharmaceuticals, LLC. All rights reserved.

 


'/>"/>
SOURCE Avion Pharmaceuticals, LLC.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Avion Pharmaceuticals, LLC., Launches Prenate Mini
2. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
3. Covis Pharmaceuticals, Inc Named US Distributor For Five Additional Products
4. Edison Pharmaceuticals, Inc. signs licensing agreement with Dainippon Sumitomo Pharma Co., Ltd. for development & commercialization of orphan mitochondrial and adult central nervous system disease drugs
5. Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
6. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc.
7. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2012 Financial Results
8. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Fourth Quarter and Year-End 2012 Financial Results
9. OncoGenex Pharmaceuticals, Inc. Provides Update on Clinical Development Program and Reports Financial Results for Fourth Quarter and Year End 2012
10. Pipeline Initiatives, Partnerships to Drive Growth - Research Report on Pfizer, Theravance, ISIS Pharmaceuticals, Infinity Pharmaceuticals and Ironwood
11. Auxilium Pharmaceuticals, Inc. to Present at the Cowen and Company 33rd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/13/2017)... ... 13, 2017 , ... “America On The Brink”: the Christian history of the ... is the creation of published author, William Nowers. Captain Nowers and his wife, ... he spent thirty years in the Navy. Following his career as a naval ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
Breaking Medicine News(10 mins):